Literature DB >> 24172055

Automated preoperative assessment of endothelial dysfunction and risk stratification for perioperative myocardial injury in patients undergoing non-cardiac surgery.

D R McIlroy1, M T V Chan, S K Wallace, J A Symons, E G Y Koo, L C Y Chu, P S Myles.   

Abstract

BACKGROUND: Myocardial injury after non-cardiac surgery (MINS) is a common complication with associated serious morbidity and mortality. Endothelial dysfunction might play an important role in MINS, and its rapid assessment could provide a novel method of risk stratification before surgery.
METHODS: We studied 238 subjects scheduled to undergo intermediate or high-risk surgery in a two-centre prospective study to determine whether preoperative endothelial dysfunction identified by a reactive hyperaemia-peripheral arterial tonometry (RH-PAT) index could provide effective risk stratification for MINS, defined as serum troponin ≥0.04 μg litre(-1), within 3 postoperative days.
RESULTS: The primary outcome occurred in 35 subjects (14.7%). Endothelial dysfunction was defined as an RH-PAT index of ≤1.22. Adjusted for age, Lee index and a composite measure of the extent of surgery, endothelial dysfunction was associated with MINS [odds ratio 10.1, 95% confidence interval (CI) 3.3-30.9, P=0.001] and increased time to discharge from hospital after surgery (hazard ratio 0.39, 95% CI 0.23-0.65, P=0.001). Endothelial dysfunction identified MINS with a sensitivity of 31%, a specificity of 96%, and a positive diagnostic likelihood ratio of 8.0. Risk classification for MINS was improved by the addition of RH-PAT-defined endothelial dysfunction to the Lee index (c-statistic increased from 0.69 to 0.77; integrated discrimination improvement 0.11, P=0.003). However, prognostic utility varied widely between sites.
CONCLUSIONS: For patients undergoing non-cardiac surgery, non-invasive assessment of endothelial function might enhance preoperative risk stratification for perioperative myocardial injury. However, unexplained large inter-site variation in prognostic utility could limit widespread application and needs to be further understood.

Entities:  

Keywords:  complications; myocardium; preoperative care; risk assessment

Mesh:

Year:  2013        PMID: 24172055     DOI: 10.1093/bja/aet354

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

Review 1.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

2.  Altered microvascular reactivity assessed by near-infrared spectroscopy after hepato-pancreato-biliary surgery.

Authors:  Kazuyuki Mizunoya; Yasunori Yagi; Yuji Morimoto; Satoshi Hirano
Journal:  J Clin Monit Comput       Date:  2021-04-07       Impact factor: 1.977

3.  Analgesic therapy improves arterial endothelial function following non-cardiovascular surgery: A randomized, placebo-controlled trial.

Authors:  Meng-Jun Wu; Meng-Chang Yang; Long-Qing Ran; Su-Mei Wei; Wen-Lai Zhou; Yong-Sheng Gou; Hai Yu
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

4.  Biomarkers as Surrogates for Coronary Endothelial Dysfunction in Patients With Nonobstructive Coronary Artery Disease.

Authors:  Anish Vani; Arthur Schwartzbard; Howard S Weintraub
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

5.  Influence of 8-Week Aerobic Training on the Skin Microcirculation in Patients with Ischaemic Heart Disease.

Authors:  Renata Szyguła; Monika Wierzbicka; Grażyna Sondel
Journal:  J Aging Res       Date:  2020-01-07

6.  Endothelial dysfunction and myocardial injury after major emergency abdominal surgery: a prospective cohort study.

Authors:  Sarah Ekeloef; Jakob Ohm Oreskov; Andreas Falkenberg; Jakob Burcharth; Anne Marie V Schou-Pedersen; Jens Lykkesfeldt; Ismail Gögenur
Journal:  BMC Anesthesiol       Date:  2020-03-16       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.